Key facts
- Finorpa is a growth equity firm based in Lille, France with 14 tracked portfolio companies.
- Notable positions include Hemerion Therapeutics, Lattice Medical, Q de Bouteilles, Sophie Lebreuilly, Extensee.
About Finorpa
Founded in 1984, Finorpa is a growth equity firm headquartered in Lille, France. The firm provides equity and quasi-equity investments in small and medium enterprises based in France.
Free account
See the whole book
- ·The book's top 25 — of 14 recorded positions
- ·Watchlist + alerts for Finorpa's activity
Create free account
No card required
Portfolio, priced
14 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Hemerion Therapeutics | — | $26.2M | — | |
| Lattice Medical | — | $11.0M | — | |
| Q de Bouteilles | — | $5.7M | — | |
| Sophie Lebreuilly | — | $5.2M | — | |
| Extensee | — | $3.5M | — | |
| Mindbaz | — | $3.2M | — | |
| Mariloo | — | $2.9M | — | |
| La Gentle Factory | — | $2.5M | — | |
| Groupe PCB | — | — | — | |
| Kovan | — | — | — | |
| EvidenceB | — | — | — | |
| Beyond Green(france) | — | — | — | |
| Focus Industrie | — | — | — | |
| Genoskin | — | — | — |
Frequently asked
- What companies does Finorpa invest in?
- Finorpa has 14 recorded portfolio companies, including Hemerion Therapeutics, Lattice Medical, Q de Bouteilles, Sophie Lebreuilly.
- What is Finorpa's AUM?
- Finorpa manages approximately $104.4M in assets.